ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amyotrophic Lateral Sclerosis Drugs Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-12C6142
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Amyotrophic Lateral Sclerosis Drugs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Amyotrophic Lateral Sclerosis Drugs Market Insights, Forecast to 2029

Code: QYRE-Auto-12C6142
Report
August 2023
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Mitsubishi Tanabe Pharma
Mylan NV
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
Eisai Co Ltd

Amyotrophic Lateral Sclerosis Drugs Market Size

The global Amyotrophic Lateral Sclerosis Drugs market is projected to grow from US$ 307.9 million in 2023 to US$ 352.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.3% during the forecast period.

Amyotrophic Lateral Sclerosis Drugs Market

Amyotrophic Lateral Sclerosis Drugs Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Drugs Market
GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.
North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent.
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.
Report Includes
This report presents an overview of global market for Amyotrophic Lateral Sclerosis Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Amyotrophic Lateral Sclerosis Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Amyotrophic Lateral Sclerosis Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Amyotrophic Lateral Sclerosis Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Amyotrophic Lateral Sclerosis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Amyotrophic Lateral Sclerosis Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Mitsubishi Tanabe Pharma, Mylan, Apotex, Glemark Generics, Sun Pharma, Covis Pharma, Lunan Pharma and CSPC Pharmaceutical, etc.

Scope of Amyotrophic Lateral Sclerosis Drugs Market Report

Report Metric Details
Report Name Amyotrophic Lateral Sclerosis Drugs Market
Accounted market size in 2023 US$ 307.9 million
Forecasted market size in 2029 US$ 352.9 million
CAGR 2.3
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Riluzole
  • Edaravone (Radicava)
  • CoQ10
  • Butylphthalide
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Mitsubishi Tanabe Pharma, Mylan, Apotex, Glemark Generics, Sun Pharma, Covis Pharma, Lunan Pharma, CSPC Pharmaceutical, Ascend Laboratories, EISAI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Amyotrophic Lateral Sclerosis Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amyotrophic Lateral Sclerosis Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis Drugs Market growing?

Ans: The Amyotrophic Lateral Sclerosis Drugs Market witnessing a CAGR of 2.3 during the forecast period 2023-2029.

What is the Amyotrophic Lateral Sclerosis Drugs Market size in 2029?

Ans: The global Amyotrophic Lateral Sclerosis Drugs market is projected to grow from US$ 307.9 million in 2023 to US$ 352.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.3% during the forecast period.

What is the market share of major companies in Amyotrophic Lateral Sclerosis Drugs Market?

Ans: Global top two manufacturers hold a share over 80%.

What is the Amyotrophic Lateral Sclerosis Drugs Market share by type?

Ans: In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 CoQ10
1.2.5 Butylphthalide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2018-2029)
2.2 Global Amyotrophic Lateral Sclerosis Drugs Growth Trends by Region
2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Region (2018-2023)
2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Region (2024-2029)
2.3 Amyotrophic Lateral Sclerosis Drugs Market Dynamics
2.3.1 Amyotrophic Lateral Sclerosis Drugs Industry Trends
2.3.2 Amyotrophic Lateral Sclerosis Drugs Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis Drugs Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Amyotrophic Lateral Sclerosis Drugs by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2018-2023)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2022
3.5 Global Key Players of Amyotrophic Lateral Sclerosis Drugs Head office and Area Served
3.6 Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Product and Application
3.7 Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2018-2023)
4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2024-2029)
5 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Application (2018-2023)
5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2018-2029)
6.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
6.2.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023)
6.2.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029)
6.2.3 North America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
6.3.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023)
6.3.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029)
6.3.3 North America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country
6.4.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2018-2023)
6.4.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2018-2029)
7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type
7.2.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023)
7.2.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029)
7.2.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application
7.3.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023)
7.3.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029)
7.3.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country
7.4.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2018-2023)
7.4.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Amyotrophic Lateral Sclerosis Drugs Market Size (2018-2029)
8.2 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type
8.2.1 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023)
8.2.2 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029)
8.2.3 China Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
8.3 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application
8.3.1 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023)
8.3.2 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029)
8.3.3 China Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Amyotrophic Lateral Sclerosis Drugs Market Size (2018-2029)
9.2 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type
9.2.1 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023)
9.2.2 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029)
9.2.3 Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
9.3 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application
9.3.1 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023)
9.3.2 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029)
9.3.3 Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
9.4 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Region
9.4.1 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2018-2023)
9.4.3 Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.1.5 Sanofi Recent Developments
11.2 Mitsubishi Tanabe Pharma
11.2.1 Mitsubishi Tanabe Pharma Company Details
11.2.2 Mitsubishi Tanabe Pharma Business Overview
11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.2.5 Mitsubishi Tanabe Pharma Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
11.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.3.5 Mylan Recent Developments
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.4.5 Apotex Recent Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Details
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.5.5 Glemark Generics Recent Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Company Details
11.6.2 Sun Pharma Business Overview
11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.6.5 Sun Pharma Recent Developments
11.7 Covis Pharma
11.7.1 Covis Pharma Company Details
11.7.2 Covis Pharma Business Overview
11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.7.5 Covis Pharma Recent Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Details
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.8.5 Lunan Pharma Recent Developments
11.9 CSPC Pharmaceutical
11.9.1 CSPC Pharmaceutical Company Details
11.9.2 CSPC Pharmaceutical Business Overview
11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
11.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.9.5 CSPC Pharmaceutical Recent Developments
11.10 Ascend Laboratories
11.10.1 Ascend Laboratories Company Details
11.10.2 Ascend Laboratories Business Overview
11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
11.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.10.5 Ascend Laboratories Recent Developments
11.11 EISAI
11.11.1 EISAI Company Details
11.11.2 EISAI Business Overview
11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
11.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
11.11.5 EISAI Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Sanofi
Mitsubishi Tanabe Pharma
Mylan NV
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
Eisai Co Ltd
List of Tables
    Table 1. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Riluzole
    Table 3. Key Players of Edaravone (Radicava)
    Table 4. Key Players of CoQ10
    Table 5. Key Players of Butylphthalide
    Table 6. Key Players of Others
    Table 7. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2018-2023)
    Table 11. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2024-2029)
    Table 13. Amyotrophic Lateral Sclerosis Drugs Market Trends
    Table 14. Amyotrophic Lateral Sclerosis Drugs Market Drivers
    Table 15. Amyotrophic Lateral Sclerosis Drugs Market Challenges
    Table 16. Amyotrophic Lateral Sclerosis Drugs Market Restraints
    Table 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Players (2018-2023)
    Table 19. Global Top Amyotrophic Lateral Sclerosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2022)
    Table 20. Global Amyotrophic Lateral Sclerosis Drugs Industry Ranking 2021 VS 2022 VS 2023
    Table 21. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Headquarters and Area Served
    Table 23. Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Product and Application
    Table 24. Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2018-2023)
    Table 28. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2024-2029)
    Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Application (2018-2023)
    Table 32. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Amyotrophic Lateral Sclerosis Drugs Revenue Share by Application (2024-2029)
    Table 34. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 35. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 36. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 37. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 38. North America Amyotrophic Lateral Sclerosis Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 40. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 42. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 43. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 44. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 45. Europe Amyotrophic Lateral Sclerosis Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 48. China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 49. China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 50. China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 51. China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 52. Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 53. Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 54. Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 55. Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 56. Asia Amyotrophic Lateral Sclerosis Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 57. Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 58. Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 64. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 66. Sanofi Company Details
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Amyotrophic Lateral Sclerosis Drugs Product
    Table 69. Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 70. Sanofi Recent Developments
    Table 71. Mitsubishi Tanabe Pharma Company Details
    Table 72. Mitsubishi Tanabe Pharma Business Overview
    Table 73. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 74. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 75. Mitsubishi Tanabe Pharma Recent Developments
    Table 76. Mylan Company Details
    Table 77. Mylan Business Overview
    Table 78. Mylan Amyotrophic Lateral Sclerosis Drugs Product
    Table 79. Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 80. Mylan Recent Developments
    Table 81. Apotex Company Details
    Table 82. Apotex Business Overview
    Table 83. Apotex Amyotrophic Lateral Sclerosis Drugs Product
    Table 84. Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 85. Apotex Recent Developments
    Table 86. Glemark Generics Company Details
    Table 87. Glemark Generics Business Overview
    Table 88. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product
    Table 89. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 90. Glemark Generics Recent Developments
    Table 91. Sun Pharma Company Details
    Table 92. Sun Pharma Business Overview
    Table 93. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 94. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 95. Sun Pharma Recent Developments
    Table 96. Covis Pharma Company Details
    Table 97. Covis Pharma Business Overview
    Table 98. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 99. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 100. Covis Pharma Recent Developments
    Table 101. Lunan Pharma Company Details
    Table 102. Lunan Pharma Business Overview
    Table 103. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 104. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 105. Lunan Pharma Recent Developments
    Table 106. CSPC Pharmaceutical Company Details
    Table 107. CSPC Pharmaceutical Business Overview
    Table 108. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product
    Table 109. CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 110. CSPC Pharmaceutical Recent Developments
    Table 111. Ascend Laboratories Company Details
    Table 112. Ascend Laboratories Business Overview
    Table 113. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product
    Table 114. Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 115. Ascend Laboratories Recent Developments
    Table 116. EISAI Company Details
    Table 117. EISAI Business Overview
    Table 118. EISAI Amyotrophic Lateral Sclerosis Drugs Product
    Table 119. EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023) & (US$ Million)
    Table 120. EISAI Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type: 2022 VS 2029
    Figure 3. Riluzole Features
    Figure 4. Edaravone (Radicava) Features
    Figure 5. CoQ10 Features
    Figure 6. Butylphthalide Features
    Figure 7. Others Features
    Figure 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2022 VS 2029
    Figure 10. Hospital Pharmacies Case Studies
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
    Figure 14. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region: 2022 VS 2029
    Figure 17. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players in 2022
    Figure 18. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2022
    Figure 20. North America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
    Figure 22. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
    Figure 23. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2018-2029)
    Figure 24. United States Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Canada Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Amyotrophic Lateral Sclerosis Drugs Market Size YoY (2018-2029) & (US$ Million)
    Figure 27. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
    Figure 28. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
    Figure 29. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2018-2029)
    Figure 30. Germany Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. France Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. U.K. Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Italy Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Russia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Nordic Countries Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. China Amyotrophic Lateral Sclerosis Drugs Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. China Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
    Figure 38. China Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
    Figure 39. Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY (2018-2029) & (US$ Million)
    Figure 40. Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
    Figure 41. Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
    Figure 42. Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2018-2029)
    Figure 43. Japan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. South Korea Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. China Taiwan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. India Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Australia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Size YoY (2018-2029) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2018-2029)
    Figure 52. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2018-2029)
    Figure 53. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Israel Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. GCC Countries Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 59. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 60. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 61. Mylan Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 62. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 63. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 64. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 65. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 66. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 67. CSPC Pharmaceutical Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 68. Ascend Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 69. EISAI Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2018-2023)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36K2790
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22U5801
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Autism Diagnostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29P12566
Mon Mar 25 00:00:00 UTC 2024

Add to Cart

Spinal Cord Stimulation Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11Z11048
Thu Mar 21 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions